Carruthers R Michael Insider Trades

Insider Trading History

Track insider trading activity for Carruthers R Michael. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Edgewise Therapeutics
Edgewise Therapeutics EWTX
Chief Financial Officer
Holding Value $628k 17,344 shares
Last Trade
Aug 12, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$77.4k 5,781 shares
$13.39
$36.21
Edgewise Therapeutics
Edgewise Therapeutics EWTX
Chief Financial Officer
Holding Value $3.12M 86,162 shares
Last Trade
Aug 12, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$19.1k 1,428 shares
$13.39
$36.21
Edgewise Therapeutics
Edgewise Therapeutics EWTX
Chief Financial Officer
Holding Value $5.84M 161,250 shares
Last Trade
Aug 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.16M 161,250 shares
$13.39
$36.21
Edgewise Therapeutics
Edgewise Therapeutics EWTX
Chief Financial Officer
Holding Value $3.17M 87,590 shares
Last Trade
Aug 12, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$77.4k 5,781 shares
$13.39
$36.21
Elevation Oncology
Elevation Oncology ELEV
Director
Holding Value $0 0 shares
Last Trade
Jul 23, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$59.9k 164,187 shares
$0.36
$0.36
Elevation Oncology
Elevation Oncology ELEV
Director
Holding Value $12.8k 35,000 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.9k 35,000 shares
$0.31
$0.36
Edgewise Therapeutics
Edgewise Therapeutics EWTX
Chief Financial Officer
Holding Value $2.93M 81,014 shares
Last Trade
May 02, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$21.6k 1,314 shares
$16.45
$36.21
Edgewise Therapeutics
Edgewise Therapeutics EWTX
Chief Financial Officer
Holding Value $2.98M 82,328 shares
Last Trade
May 01, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$86.9k 5,209 shares
$16.68
$36.21
Edgewise Therapeutics
Edgewise Therapeutics EWTX
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
May 01, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$86.9k 5,209 shares
$16.68
$36.21
Edgewise Therapeutics
Edgewise Therapeutics EWTX
Chief Financial Officer
Holding Value $2.78M 76,904 shares
Last Trade
Oct 11, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.23M 70,000 shares
$31.92
$36.21
Edgewise Therapeutics
Edgewise Therapeutics EWTX
Chief Financial Officer
Holding Value $4.6M 127,122 shares
Last Trade
Oct 11, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.23M 70,000 shares
$31.92
$36.21
Edgewise Therapeutics
Edgewise Therapeutics EWTX
Chief Financial Officer
Holding Value $1.3M 35,928 shares
Last Trade
Sep 20, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.57M 125,092 shares
$28.57
$36.21
Edgewise Therapeutics
Edgewise Therapeutics EWTX
Chief Financial Officer
Holding Value $2.97M 81,996 shares
Last Trade
Sep 20, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.72M 96,068 shares
$28.28
$36.21
Edgewise Therapeutics
Edgewise Therapeutics EWTX
Chief Financial Officer
Holding Value $1.48M 40,990 shares
Last Trade
Sep 20, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.72M 96,068 shares
$28.28
$36.21
Edgewise Therapeutics
Edgewise Therapeutics EWTX
Chief Financial Officer
Holding Value $5.02M 138,750 shares
Last Trade
Aug 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.37M 138,750 shares
$17.05
$36.21
Elevation Oncology
Elevation Oncology ELEV
Director
Holding Value $12.8k 35,000 shares
Last Trade
Jun 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$117k 35,000 shares
$3.35
$0.36
Edgewise Therapeutics
Edgewise Therapeutics EWTX
Chief Financial Officer
Holding Value $1.28M 35,230 shares
Last Trade
May 02, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$40.8k 2,157 shares
$18.91
$36.21
Edgewise Therapeutics
Edgewise Therapeutics EWTX
Chief Financial Officer
Holding Value $1.35M 37,387 shares
Last Trade
May 01, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$99k 5,208 shares
$19.01
$36.21
Edgewise Therapeutics
Edgewise Therapeutics EWTX
Chief Financial Officer
Holding Value $189k 5,209 shares
Last Trade
May 01, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$99k 5,208 shares
$19.01
$36.21
Edgewise Therapeutics
Edgewise Therapeutics EWTX
Chief Financial Officer
Holding Value $4.96M 137,058 shares
Last Trade
Jan 23, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.39M 90,000 shares
$15.46
$36.21

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up